Apeiron Capital Investment (APN) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Apeiron Capital Investment Corp   (NYSE: APN)


Apeiron Capital Investment 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Apeiron Capital Investment 's ROA in the first quarter of 2023?
Apeiron Capital Investment Corp achieved a return on average assets (ROA) of 2.24 % in its first quarter of 2023, which is below Apeiron Capital Investment 's average return on assets, which stands at 4.01%.

ROA fell compared to the fourth quarter of 2022, despite the net income growth of % from the fourth quarter of 2022.

However, within the Healthcare sector 213 other companies had a higher return on assets. While the total ranking for ROA unchanged, relative to the fourth quarter of 2022 at no. .

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Total Assets Change -90.65 % -90.25 % 58899.61 % - -
Y / Y Net Income Change -83.09 % - - - -
Net Income (TTM) in million 2 7 8 7 6
Return On Assets (TTM) 2.24 % 4.8 % 4.37 % 5.26 % 6.54 %
APN's Total Ranking # # # # #
Total Assets (TTM) in million 17 17 178 177 177
Seq. Total Assets Change -4.25 % -90.28 % 0.45 % -0.05 % -0.1 %
Seq. Net Income Change - - -37.63 % -77.47 % 979.98 %

APN's 5 Years Annual ROA >> Back to APN Management Effectiveness >> Compare APN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 17
Sector # 214
Overall # 2134

Return On Assets Statistics
High Average Low
4.89 %
4.01 %
2.24 %
(Jun 30 2022)   (Mar 31 2023)





Financial Statements
Apeiron Capital Investment 's Assets $ 17 million APN's Balance sheet
Apeiron Capital Investment 's Income $ 1 million Quarterly APN's Income Statement
APN's Income by Division See APN's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
FY
Y / Y Total Assets Change -90.25 % - - - -
Total Assets in million 17 177 0 0 0
Y / Y Net Income Change 1253.19 % - - - -
Net Income in million 7 0 0 0 0
Annual Return On Assets 38.11 % 0.27 % - - -

APN's 5 Years Annual ROA >> Back to APN Management Effectiveness >> Compare APN ROA to its Competitors



Comment on APN's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA improved to 38.11 % compared to prior year, due to annual net income growth of 1253.19 % to $6.58 million, and due to decline of value in Apeiron Capital Investment 's assets by -90.25 % to $17.27 million, compared to $17.27 a year before.


More Return On Assets Ratios
APN's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
APN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for APN's Competitors
Subscribers only: Roa for Apeiron Capital Investment 's Suppliers
Subscribers only: Return On Assets for APN's Customers

You may also want to know
APN's Roi APN's Inventory Turnover Ratio APN's Growth Rates APN's Dividend Comparisons
APN's Profitability Ratios APN's Asset Turnover Ratio APN's Dividend Growth
APN's Roe APN's Valuation Ratios APN's Financial Strength Ratios APN's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA
Electromed Inc   6.07 %
Escalon Medical Corp   6.05 %
Cadre Holdings inc   6.03 %
Henry Schein Inc   5.97 %
Incyte Corporation  5.77 %
Acadia Healthcare Company Inc   5.73 %
Amedisys Inc  5.61 %
Dexcom Inc   5.57 %
Abbvie Inc   5.44 %
Integrated Biopharma Inc  5.43 %
Align Technology inc   5.35 %
Addus Homecare Corp  5.32 %
Teleflex Incorporated  5.31 %
Third Harmonic Bio Inc   5.26 %
Option Care Health Inc   5.19 %
U S Physical Therapy Inc  5.16 %
Merit Medical Systems Inc  5.12 %
Viemed Healthcare Inc   5.01 %
Universal Health Services Inc   4.98 %
Labcorp Holdings Inc   4.97 %
Telesis Bio Inc   4.97 %
Healthcare Services Group Inc   4.82 %
Exicure Inc   4.80 %
Avantor Inc   4.63 %
Thorne Healthtech Inc   4.55 %
Integra Lifesciences Holdings Corp  4.53 %
Redwoods Acquisition Corp  4.48 %
Davita Inc   4.41 %
Pediatrix Medical Group Inc   4.34 %
Cryo cell International Inc   4.28 %

Date modified: 2026-09-26T07:41:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.